BEIJING, Nov. 29 (Chinese media) -- China's drug safety
watchdog on Saturday ordered a nationwide overhaul of intravenous and herbal
injections following a series of contamination incidents.
The State Food and Drug Administration (SFDA) said
local bureaus have to finish checks on all injections produced within their
respective jurisdictions before the end of the year.
The filed information should include how an injection
was produced, the ingredients, what equipment was used, package suppliers,
adverse reactions, data from quality spot-checks and risk evaluation.
The SFDA hopes the process will rule out hidden
safety problems and reduce risks.
In October, three patients in the southwestern Yunnan
Province became sick and another three died after receiving an herbal ciwujia
injection produced by the Wandashan Pharmaceutical Company. The medicine was
contaminated with bacteria after being exposed to rain.
No comments:
Post a Comment